Showing results (891-900 of 2,578) with videos related to
Sort By:
Pageof 258
Molecular Oncology|September 11, 2014
Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapyNada Albarakati, Tarek M A Abdel-Fatah, Rachel Doherty, et al.Molecular Oncology|September 18, 2014
Hurdles on the road to personalized medicineThomas Tursz, Rene BernardsMolecular Oncology|August 13, 2014
Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stressIlya N Kotov, Ellen Siebring-van Olst, Philip A Knobel, et al.Molecular Oncology|August 2, 2014
Optimal design of trials to demonstrate the utility of genomically-guided therapy: Putting Precision Cancer Medicine to the testRodrigo Dienstmann, Jordi Rodon, Josep TaberneroMolecular Oncology|July 30, 2013
Progression from ductal carcinoma in situ to invasive breast cancer: revisitedCatherine F Cowell, Britta Weigelt, Rita A Sakr, et al.Molecular Oncology|July 23, 2014
A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patientsSeon-Kyu Kim, Seon-Young Kim, Jeong-Hwan Kim, et al.Molecular Oncology|November 6, 2013
An integrative framework identifies alternative splicing events in colorectal cancer developmentAndrea Bisognin, Silvia Pizzini, Lisa Perilli, et al.Molecular Oncology|August 31, 2013
p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemiaJun Zhang, Christopher S Seet, Clare Sun, et al.Molecular Oncology|September 3, 2013
Epithelial-mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4-ALK translocationHyeong Ryul Kim, Woo Sung Kim, Yun Jung Choi, et al.Molecular Oncology|August 7, 2013
Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulationAnsgar Brüning, Martina Rahmeh, Klaus FriesePageof 258